What is the recommended dosage for 락토바실루스 람노서스 GG?

General: 10-20 billion CFU/day; Ibs Support: 10 billion CFU/day for 4-8 weeks; Aad Prevention: 10-20 billion CFU/day (start with antibiotic, continue 7 days after)

What are the side effects of 락토바실루스 람노서스 GG?

Potential side effects include: Mild gas and bloating during initial use (usually resolves in 1-2 weeks), Rare reports of bacteremia in severely immunocompromised individuals, Occasional loose stools during adjustment period, Very rare: systemic infection in critically ill patients with central venous catheters.

What is Lactobacillus rhamnosus GG and how does it work for gut health?

Lactobacillus rhamnosus GG (LGG) is the most extensively studied probiotic strain in the world, with over 1,000 published studies. It has unique pili (hair-like structures) that help it adhere to the intestinal wall, enhancing its colonization and interaction with the immune system. Research demonstrates its efficacy in preventing and treating acute diarrhea, reducing antibiotic-associated diarrhea, and supporting overall gut barrier function.

What is the recommended dosage of Lactobacillus rhamnosus GG?

Clinical evidence supports dosages of 1 billion to 20 billion CFU per day, with 10-20 billion CFU being commonly used in adult studies. For prevention of antibiotic-associated diarrhea, it is typically started at the same time as antibiotic therapy and continued for 1-2 weeks after completion. LGG is available in capsules, powders, and dairy products.

Are there side effects or interactions with Lactobacillus rhamnosus GG?

LGG has the most comprehensive safety data of any probiotic strain and is well-tolerated by children, adults, and elderly individuals. Rare cases of bacteremia have been reported in severely immunocompromised patients, so LGG should be avoided in individuals with central venous catheters or severe immune deficiency. For the general population, it is considered very safe.

락토바실루스 람노서스 GG
Lactobacillus rhamnosus GG

probiotic_strain

다른 이름: LGG, Lacticaseibacillus rhamnosus GG, ATCC 53103, Lactobacillus rhamnosus GG

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Drhamnosus\u002Dgg'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

About

락토바실루스 람노서스 GG(LGG)는 1,000건이 넘는 임상연구로 뒷받침되는, 세계에서 가장 광범위하게 연구된 프로바이오틱 균주 중 하나입니다. 밀착연접 단백질의 발현을 상향조절해 장벽 기능을 지원하며, 톨유사수용체 신호전달을 통해 장 면역반응을 조절하는 데 도움이 될 수 있습니다. 연구에 따르면 LGG는 특히 항생제 관련 소화 문제와 전반적인 소화 편안함 지원에 유익할 수 있습니다.

How It Works

밀착연접 단백질(클라우딘-1, 오클루딘, ZO-1)의 발현을 상향조절해 장벽 기능을 강화하며, 톨유사수용체 신호전달을 통해 장 면역반응을 조절하고, 상피세포에서 사이토카인 유발 세포자멸사를 예방하는 Akt 경로를 활성화하는 가용성 인자 p75와 p40을 생성합니다.

Evidence For Conditions

건강 상태	등급	연구	참여자
항생제 관련 설사(AAD)	A	20	4000	보기 →
과민성 대장 증후군(IBS)	B	8	1200	보기 →

Side Effects

Mild gas and bloating during initial use (usually resolves in 1-2 weeks)
Rare reports of bacteremia in severely immunocompromised individuals
Occasional loose stools during adjustment period
Very rare: systemic infection in critically ill patients with central venous catheters

Drug & Supplement Interactions

Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
Immunosuppressants (theoretical risk of infection in immunocompromised patients)
Antifungals (no known interaction but may affect gut flora balance)

복용 중인 모든 건강기능식품에 대해 반드시 의료 전문가에게 알리십시오.

비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 브레베 비피도박테리움 비피덤 사카로마이세스 보울라디

핵심 정보

용량: General: 10-20 billion CFU/day; Ibs_Support: 10 billion CFU/day for 4-8 weeks; Aad_Prevention: 10-20 billion CFU/day (start with antibiotic, continue 7 days after)
제형: capsule powder sachet chewable tablet
천연 원료: Fermented dairy products, Available primarily as commercial probiotic supplements
상한 섭취량: Generally well-tolerated up to 40 billion CFU/day in clinical trials
권장 복용 시간: On an empty stomach or 30 minutes before meals for optimal survival

근거 요약

항생제 관련 설사(AAD) A

과민성 대장 증후군(IBS) B

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.